Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aripiprazole 10mg tablets
0402010ADAAAAAA
|
Aripiprazole | Aripiprazole | Central Nervous System | 133,344 |
|
Aripiprazole 5mg tablets
0402010ADAAADAD
|
Aripiprazole | Aripiprazole | Central Nervous System | 107,762 |
|
Aripiprazole 15mg tablets
0402010ADAAABAB
|
Aripiprazole | Aripiprazole | Central Nervous System | 88,805 |
|
Aripiprazole 30mg tablets
0402010ADAAACAC
|
Aripiprazole | Aripiprazole | Central Nervous System | 14,459 |
|
Aripiprazole 1mg/ml oral solution
0402010ADAAAGAG
|
Aripiprazole | Aripiprazole | Central Nervous System | 8,551 |
|
Aripiprazole 10mg orodispersible tablets sugar free
0402010ADAAAEAE
|
Aripiprazole | Aripiprazole | Central Nervous System | 3,090 |
|
Aripiprazole 400mg inj pre-filled syringes
0402020ADAAABAB
|
Aripiprazole | Aripiprazole | Central Nervous System | 2,389 |
|
Aripiprazole 15mg orodispersible tablets sugar free
0402010ADAAAFAF
|
Aripiprazole | Aripiprazole | Central Nervous System | 2,235 |
|
Aripiprazole 1mg/ml oral solution sugar free
0402010ADAAAKAK
|
Aripiprazole | Aripiprazole | Central Nervous System | 1,941 |
|
Aripiprazole 400mg inj vials
0402020ADAAAAAA
|
Aripiprazole | Aripiprazole | Central Nervous System | 1,711 |
|
Abilify 10mg tablets
0402010ADBBAAAA
|
Abilify | Aripiprazole | Central Nervous System | 1,085 |
|
Abilify 5mg tablets
0402010ADBBADAD
|
Abilify | Aripiprazole | Central Nervous System | 813 |
|
Aripiprazole 2.5mg tablets
0402010ADAAAMAM
|
Aripiprazole | Aripiprazole | Central Nervous System | 489 |
|
Abilify 15mg tablets
0402010ADBBABAB
|
Abilify | Aripiprazole | Central Nervous System | 456 |
|
Abilify Maintena 400mg inj pre-filled syringes
0402020ADBBABAB
|
Abilify Maintena | Aripiprazole | Central Nervous System | 184 |
|
Abilify Maintena 400mg inj vials
0402020ADBBAAAA
|
Abilify Maintena | Aripiprazole | Central Nervous System | 151 |
|
Abilify 1mg/ml oral solution
0402010ADBBAGAG
|
Abilify | Aripiprazole | Central Nervous System | 139 |
|
Abilify 30mg tablets
0402010ADBBACAC
|
Abilify | Aripiprazole | Central Nervous System | 56 |
|
Aripiprazole 1mg tablets
0402010ADAAALAL
|
Aripiprazole | Aripiprazole | Central Nervous System | 25 |
|
Abilify 10mg orodispersible tablets
0402010ADBBAEAE
|
Abilify | Aripiprazole | Central Nervous System | 23 |
|
Abilify 15mg orodispersible tablets
0402010ADBBAFAF
|
Abilify | Aripiprazole | Central Nervous System | 21 |
|
Arpoya 5mg tablets
0402010ADBDAAAD
|
Arpoya | Aripiprazole | Central Nervous System | 6 |
|
Arpoya 10mg tablets
0402010ADBDABAA
|
Arpoya | Aripiprazole | Central Nervous System | 5 |
|
Aripiprazole 9.75mg/1.3ml solution for injection vials
0402010ADAAAHAH
|
Aripiprazole | Aripiprazole | Central Nervous System | 3 |
|
Aripiprazole 720mg/2.4ml prolonged-release inj pf syringes
0402020ADAAADAD
|
Aripiprazole | Aripiprazole | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.